23/07/2003
ReGen Therapeutics Plc (the ‘Company’) announces that it was notified on 22 July 2003 that, pursuant to a placing, Hoodless Brennan & Partners Plc (‘Hoodless’) acquired 28,593,335 ordinary shares of the Company on 22 July 2003 representing 17.77% of the issued share capital of the Company. On the same date, Hoodless sold 28,593,335 ordinary shares and no longer has a notifiable interest in the Company.
For further information, please contact:
Andrew Marshall
Marshall Robinson Roe
Tel. 020 7489 2033